Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2021 - 05 - 14

Menarini receives the coveted M&A Award 2021 for the 2020 acquisition of US company Stemline Therapeutics

Florence, 14th May 2021 - Menarini Group takes home the prestigious  M&A Award 2021 for the “Italy acquires Abroad“ category in recognition of their landmark acquisition of Stemline Therapeutics, a U.S. biotechnology company focused on oncology treatments based in New York and formerly quoted on NASDAQ.

2020 was an unprecedentedly arduous year around the world and the pandemic hit many different industrial sectors very hard. For the pharmaceutical and healthcare sectors it was no different and to enter into a $677 million acquisition, take over 100% of the shares to a U.S. biotechnological company, expand the Group’s research and development capabilities and enhance their commitment to oncology therapeutics in the middle of a global pandemic, was a bold move.

This strategic move was acknowledged by a selected jury at the XVII edition of the M&A Award, an initiative founded by KPMG and Fineurop Soditic, which took place virtually on 13th May 2021 and was broadcast by Class CNBC.

The organisers of the event, KPMG and Fineurop Soditic said: “The Jury decided to acknowlege one of Italy’s leading pharmaceutical companies, Menarini, for their acquisition of U.S. company, Stemline Therapeutics, and for having demonstrated entrepreneurial courage in continuing its growth through international acquisitions, despite the difficulties deriving from the pandemic”.

Elcin Barker Ergun

During the ceremony the prize was conferred to CEO and Board Member of Menarini Group, Elcin Barker Ergun, who commented: “We feel extremely proud to have been awarded with this accolade in recognition of our acquisition of Stemline and the growth and expansion possibilities that this acquisition has brought with it. Stemline’s world class R&D capabilities will help Menarini bring forth new and innovative therapeutics, for the benefit of patients suffering from cancer”.

About KPMG:

KPMG International operates as a network of member firms offering audit, tax and advisory services in over 146 countries throughout the world and with 227,000 professionals. The KPMG Network has been operating in Italy since 1958. Today, with more than 4,000 professionals and 200 Partners operating in 25 major Italian cities, over 6,000 clients and a full service portfolio which addresses national and international markets’ requirements, it is recognized by its stakeholders as the most important provider of professional services in Italy.

About Fineurop Soditic:

Fineurop Soditic is an independent corporate finance boutique established in 1998. Its activities range from mergers and acquisitions to debt advisory and acquisition financing. Headquartered in Milan, it has an extensive international network. Fineurop Soditic has successfully concluded over 550 domestic and cross border transactions, on behalf of clients including international private equity firms and corporates looking to make acquisitions in Italy and local companies wishing to sell, restructure or refinance their businesses. It has established a position as a leading player in the Italian market with a particular focus on mid-sized businesses.